Evidence map›Paper›PMID 37904764›Full record

ArticleMagnetic resonance (Gottingen, Germany)2021

Nuclear magnetic resonance free ligand conformations and atomic resolution dynamics.

Amber Y S Balazs, Nichola L Davies, David Longmire, Martin J Packer, Elisabetta Chiarparin

Abstract read
In one paragraph

Article in Magnetic resonance (Gottingen, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Introduction to "Geoffrey Bodenhausen Festschrift".Magnetic resonance (Gottingen, Germany) · 2023
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Amber Y S BalazsChemistry, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.
Nichola L DaviesChemistry, Oncology R&D, AstraZeneca, Cambridge CB4 0QA, United Kingdom.
David LongmireChemistry, Oncology R&D, AstraZeneca, Cambridge CB4 0QA, United Kingdom.
Martin J PackerChemistry, Oncology R&D, AstraZeneca, Cambridge CB4 0QA, United Kingdom.
Elisabetta ChiarparinChemistry, Oncology R&D, AstraZeneca, Cambridge CB4 0QA, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Knowledge of free ligand conformational preferences (energy minima) and conformational dynamics (rotational energy barriers) of small molecules in solution can guide drug design hypotheses and help rank ideas to bias syntheses towards more active compounds. Visualization of conformational exchange dynamics around torsion angles, by replica exchange with solute tempering molecular dynamics (REST-MD), gives results in agreement with high-resolution

Identifiers

PMID37904764
PMCPMC10539760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.